Development of a Complex Biofeedback-Based Intervention to Improve Methotrexate Adherence in Rheumatoid Arthritis: A COM-B Model Informed Qualitative Study. [PDF]
Shafi H +5 more
europepmc +1 more source
ABSTRACT Background Lebrikizumab is approved to treat patients with moderate‐to‐severe atopic dermatitis (AD). Objectives This study evaluated the 16‐week efficacy outcomes of lebrikizumab in adults and adolescents with severe AD in ADvocate trials who would be eligible for treatment based on South Korean reimbursement‐like criteria. Methods This was a
Chong Hyun Won +11 more
wiley +1 more source
Primary vitreoretinal lymphoma: diagnostic and therapeutic insights from a Slovenian population-based study. [PDF]
Vrabič N +8 more
europepmc +1 more source
JAK Inhibitors in Psoriatic–Atopic Dermatitis Overlap: A Four‑Case Series
ABSTRACT Overlap between psoriasis and atopic dermatitis (AD) poses diagnostic and therapeutic challenges; monoclonal antibodies targeting a single axis may improve one component while worsening the other [1]. Janus kinase (JAK) inhibitors act pleiotropically and may provide simultaneous control of psoriatic and eczematous inflammation [2].
Eleonora Bongiovanni +6 more
wiley +1 more source
Tocilizumab in the treatment of IgG4-related disease involving the carotid artery-case report and literature review. [PDF]
Ding X, Tao J, Xu C, Han Y.
europepmc +1 more source
Drug Survival of Acitretin and Methotrexate in Adult Psoriasis Patients.
Erkayman MH, Ergun T.
europepmc +1 more source
Effective Local Methotrexate Therapy for Interstitial Ectopic Pregnancy: A Case Report and Review of the Literature. [PDF]
Alabbad NS +4 more
europepmc +1 more source
Correction to "Clinical Risk Factors for High-Dose Methotrexate-Induced Oral Mucositis Following Individualized Dosing". [PDF]
europepmc +1 more source

